Your browser doesn't support javascript.
loading
CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis.
Clarkson, Benjamin Ds; Grund, Ethan M; Standiford, Miranda M; Mirchia, Kanish; Westphal, Maria S; Muschler, Liz S; Howe, Charles L.
Afiliación
  • Clarkson BD; Department of Neurology.
  • Grund EM; Department of Laboratory Medicine and Pathology.
  • Standiford MM; Center for Multiple Sclerosis and Autoimmune Neurology.
  • Mirchia K; Mayo Graduate School.
  • Westphal MS; Medical Scientist Training Program.
  • Muschler LS; Mayo Graduate School.
  • Howe CL; Department of Neurology.
J Clin Invest ; 133(21)2023 11 01.
Article en En | MEDLINE | ID: mdl-37676734
ABSTRACT
CD8+ T cells outnumber CD4+ cells in multiple sclerosis (MS) lesions associated with disease progression, but the pathogenic role and antigenic targets of these clonally expanded effectors are unknown. Based on evidence that demyelination is necessary but not sufficient for disease progression in MS, we previously hypothesized that CNS-infiltrating CD8+ T cells specific for neuronal antigens directly drive the axonal and neuronal injury that leads to cumulative neurologic disability in patients with MS. We now show that demyelination induced expression of MHC class I on neurons and axons and resulted in presentation of a neuron-specific neoantigen (synapsin promoter-driven chicken ovalbumin) to antigen-specific CD8+ T cells (anti-ovalbumin OT-I TCR-transgenic T cells). These neuroantigen-specific effectors surveilled the CNS in the absence of demyelination but were not retained. However, upon induction of demyelination via cuprizone intoxication, neuroantigen-specific CD8+ T cells proliferated, accumulated in the CNS, and damaged neoantigen-expressing neurons and axons. We further report elevated neuronal expression of MHC class I and ß2-microglobulin transcripts and protein in gray matter and white matter tracts in tissue from patients with MS. These findings support a pathogenic role for autoreactive anti-axonal and anti-neuronal CD8+ T cells in MS progression.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article